Europe Sustained Release Excipients Market Size to 2022-2028

Europe Sustained Release Excipients Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Product (Polymers, Minerals, Sugars, Gelatin & Chitosan), By Technology, By Country and Growth Forecast, 2022 - 2028

Published Date: November-2022 | Number of Pages: 105 | Format: PDF | Report ID: KBV-21132

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the Europe Sustained Release Excipients Market

Market Report Description

The Europe Sustained Release Excipients Market would witness market growth of 8.1% CAGR during the forecast period (2022-2028).

Methacrylate polymers, which also offer gastro-resistant functionality, are frequently utilized in delayed-release dosage forms. Although the usage of two-polymer matrix systems is expanding, hydroxypropyl methylcellulose (HPMC) remains the excipient of choice in monolithic delivery systems. Matrix systems and functional coatings are the two main formulation techniques that can be used to create sustained release kinetics.

In order to produce a membrane surrounding the tablet that regulates the pace of API release in relation to the rate of coating layer evaporation through which the medicine will diffuse and dissolve, functional coatings are used. These reservoir systems are another name for such sustained release systems. This strategy can be flexible because the pores, coating type, and thickness can all be changed to alter the controlled release profile. The API is uniformly disseminated within a matrix made of polymers in formulations for sustained release based on a matrix.

Matrix systems are divided into hydrophobic and hydrophilic matrix systems based on the rate-controlling polymeric characteristics, which exhibit various release mechanisms. The API is released by diffusion through the thick gel layer and also by matrix erosion in the hydrophilic type of matrix systems. In this, the polymer hydrates and expands upon contact with the gastrointestinal medium, generating a gel layer on the system's surface. Different polymer kinds, grades, and quantities can be used to modify released kinetics, but they also depend on the solubility of the API.

Due to the aging populations, non-communicable diseases, multimorbidity, and frailty in Europe, the emergence of diseases like COVID-19 are especially pertinent. A study conducted throughout the region reported that the nations with the largest percentages of senior citizens were Finland, Italy, Greece, Portugal, and Germany. The report indicated that in these countries older people were living with disabilities on average. But the greatest rates were found in Bulgaria, Croatia, and Hungary. Additionally, the region's burden of cardiovascular diseases (CVD) goes beyond mortality. A high prevalence of the disease/disorder is observed in Eastern Europe than in the western part.

The Germany market dominated the Europe Sustained Release Excipients Market by Country in 2021; thereby, achieving a market value of $153.4 million by 2028. The UK market would showcase a CAGR of 7.2% during (2022 - 2028). Additionally, The France market is anticipated to grow at a CAGR of 8.9% during (2022 - 2028).

Based on Route of Administration, the market is segmented into Oral, Transdermal, Vaginal, Intravenous, Ophthalmic, Subcutaneous, Intramuscular, and Others. Based on Product, the market is segmented into Polymers, Minerals, Sugars, Gelatin & Chitosan, and Others. Based on Technology, the market is segmented into Targeted Delivery, Implants, Wurster Technique, Transdermal, Micro Encapsulation, and Coacervation & Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Sustained Release Excipients Market will Hit $1.9 Billion by 2028, at a CAGR of 8.4%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BASF SE, International Flavors & Fragrances, Inc., Ashland Global Holdings Inc., Evonik Industries AG, Croda International Plc, Gattefossé, Merck Group, Pfizer, Inc., Novartis AG and AstraZeneca Plc.

Scope of the Study

Market Segments Covered in the Report:

By Route of Administration

  • Oral
  • Transdermal
  • Vaginal
  • Intravenous
  • Ophthalmic
  • Subcutaneous
  • Intramuscular
  • Others

By Product

  • Polymers
  • Minerals
  • Sugars
  • Gelatin & Chitosan
  • Others

By Technology

  • Targeted Delivery
  • Implants
  • Wurster Technique
  • Transdermal
  • Micro Encapsulation
  • Coacervation & Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • BASF SE
  • International Flavors & Fragrances, Inc.
  • Ashland Global Holdings Inc.
  • Evonik Industries AG
  • Croda International Plc
  • Gattefossé
  • Merck Group
  • Pfizer, Inc.
  • Novartis AG
  • AstraZeneca Plc

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Sustained Release Excipients Market Report 2022-2028

North America Sustained Release Excipients Market Report 2022-2028

Asia Pacific Sustained Release Excipients Market Report 2022-2028

LAMEA Sustained Release Excipients Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities